Blood Cells: an Historical Account of the Roles of Purinergic Signalling

Overview

Journal Purinergic Signal

Publisher Springer

Date 2015 Aug 12

PMID 26260710

Citations 30

Authors

Geoffrey Burnstock

Affiliations

Soon will be listed here.

Abstract

The involvement of purinergic signalling in the physiology of erythrocytes, platelets and leukocytes was recognised early. The release of ATP and the expression of purinoceptors and ectonucleotidases on erythrocytes in health and disease are reviewed. The release of ATP and ADP from platelets and the expression and roles of P1, P2Y(1), P2Y(12) and P2X1 receptors on platelets are described. P2Y(1) and P2X(1) receptors mediate changes in platelet shape, while P2Y(12) receptors mediate platelet aggregation. The changes in the role of purinergic signalling in a variety of disease conditions are considered. The successful use of P2Y(12) receptor antagonists, such as clopidogrel and ticagrelor, for the treatment of thrombosis, myocardial infarction and stroke is discussed.

Citing Articles

Identification of purinergic system components in the venom of Bothrops mattogrossensis and the inhibitory effect of specioside extracted from Tabebuia aurea.

Dias D, Souza de Souza K, Moslaves I, Buri M, Luiz Soares Basilio D, Teixeira Espinoca I Purinergic Signal. 2024; .

PMID: 38958820 DOI: 10.1007/s11302-024-10032-z.

Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation.

Kiaie S, Hatami Z, Nasr M, Pazooki P, Hemmati S, Baradaran B Purinergic Signal. 2023; 20(4):321-343.

PMID: 37843749 PMC: 11303644. DOI: 10.1007/s11302-023-09966-7.

Effects of uridine and nucleotides on hemostasis parameters.

Ari M, Sagdilek E, Kilinc E, Cansev M, Ozluk K J Thromb Thrombolysis. 2023; 55(4):626-633.

PMID: 36961669 DOI: 10.1007/s11239-023-02793-y.

Platelets and the Cybernetic Regulation of Ischemic Inflammatory Responses through PNC Formation Regulated by Extracellular Nucleotide Metabolism and Signaling.

Granja T, Kohler D, Leiss V, Eggstein C, Nurnberg B, Rosenberger P Cells. 2022; 11(19).

PMID: 36230973 PMC: 9561997. DOI: 10.3390/cells11193009.

Metabolic Influences Modulating Erythrocyte Deformability and Eryptosis.

Brun J, Varlet-Marie E, Myzia J, Raynaud de Mauverger E, Pretorius E Metabolites. 2022; 12(1).

PMID: 35050126 PMC: 8778269. DOI: 10.3390/metabo12010004.

References

Packham M, Rand M . Historical perspective on ADP-induced platelet activation. Purinergic Signal. 2011; 7(3):283-92. PMC: 3166988. DOI: 10.1007/s11302-011-9227-x. View

Fredman G, Van Dyke T, Serhan C . Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol. 2010; 30(10):2005-13. PMC: 2982748. DOI: 10.1161/ATVBAHA.110.209908. View

Dionisotti S, Zocchi C, Varani K, Borea P, Ongini E . Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(6):673-6. DOI: 10.1007/BF00168741. View

Uneyama H, Uneyama C, Ebihara S, Akaike N . Suramin and reactive blue 2 are antagonists for a newly identified purinoceptor on rat megakaryocyte. Br J Pharmacol. 1994; 111(1):245-9. PMC: 1910005. DOI: 10.1111/j.1476-5381.1994.tb14051.x. View

Stevenson R, Taylor R, Wiley J, Sluyter R . The P2X(7) receptor mediates the uptake of organic cations in canine erythrocytes and mononuclear leukocytes: comparison to equivalent human cell types. Purinergic Signal. 2009; 5(3):385-94. PMC: 2717320. DOI: 10.1007/s11302-009-9163-1. View

Gurung I, Martinez-Pinna J, Mahaut-Smith M . Novel consequences of voltage-dependence to G-protein-coupled P2Y1 receptors. Br J Pharmacol. 2008; 154(4):882-9. PMC: 2439842. DOI: 10.1038/bjp.2008.97. View

Angiolillo D, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass T . Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol. 2007; 49(14):1505-16. DOI: 10.1016/j.jacc.2006.11.044. View

Cattaneo M . Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate. Thromb Haemost. 2011; 105 Suppl 1:S67-74. DOI: 10.1160/THS10-11-0742. View

Tello-Montoliu A, Jover E, Rivera J, Valdes M, Angiolillo D, Marin F . New perspectives in antiplatelet therapy. Curr Med Chem. 2012; 19(3):406-27. DOI: 10.2174/092986712803414240. View

10.

Pochmann D, Bohmer A, Bruno A, Sarkis J . Ecto-hydrolysis of adenine nucleotides in rat blood platelets are altered by ovariectomy. Platelets. 2005; 16(6):334-9. DOI: 10.1080/09537100500124400. View

11.

Yusuf S, Zhao F, Mehta S, Chrolavicius S, Tognoni G, Fox K . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001; 345(7):494-502. DOI: 10.1056/NEJMoa010746. View

12.

Oury C, Toth-Zsamboki E, Vermylen J, Hoylaerts M . The platelet ATP and ADP receptors. Curr Pharm Des. 2006; 12(7):859-75. DOI: 10.2174/138161206776056029. View

13.

Cusack N, Born G . Inhibition of adenosine deaminase and of platelet aggregation by 2-azidoadenosine, a photolysable analogue of adenosine. Proc R Soc Lond B Biol Sci. 1976; 193(1112):307-11. DOI: 10.1098/rspb.1976.0048. View

14.

Jarvis G, Humphries R, Robertson M, Leff P . ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors. Br J Pharmacol. 2000; 129(2):275-82. PMC: 1571831. DOI: 10.1038/sj.bjp.0703046. View

15.

VIGNE P, Hechler B, Gachet C, Breittmayer J, Frelin C . Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Biochem Biophys Res Commun. 1999; 256(1):94-7. DOI: 10.1006/bbrc.1999.9558. View

16.

Amisten S, Braun O, Bengtsson A, Erlinge D . Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb Res. 2007; 122(1):47-57. DOI: 10.1016/j.thromres.2007.08.014. View

17.

Michelson A . Advances in antiplatelet therapy. Hematology Am Soc Hematol Educ Program. 2011; 2011:62-9. DOI: 10.1182/asheducation-2011.1.62. View

18.

Chang H, Yanachkov I, Michelson A, Li Y, Barnard M, Wright G . Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors. Thromb Res. 2009; 125(2):159-65. PMC: 2826549. DOI: 10.1016/j.thromres.2009.11.006. View

19.

Sprague R, Hanson M, Achilleus D, Bowles E, Stephenson A, Sridharan M . Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension. Pharmacol Rep. 2009; 61(1):183-90. PMC: 2906251. DOI: 10.1016/s1734-1140(09)70020-9. View

20.

Tanneur V, Duranton C, Brand V, Sandu C, Akkaya C, Kasinathan R . Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J. 2005; 20(1):133-5. DOI: 10.1096/fj.04-3371fje. View